Copyright
©The Author(s) 2003.
World J Gastroenterol. Jul 15, 2003; 9(7): 1487-1490
Published online Jul 15, 2003. doi: 10.3748/wjg.v9.i7.1487
Published online Jul 15, 2003. doi: 10.3748/wjg.v9.i7.1487
Table 1 Baseline characteristics of patients
| Patients (n) | 189 | |
| Age (year) ± SD | 58 ± 18 | |
| Sex (M/F) | 95/94 | |
| ALT (U/L) ± SE | 142 ± 8 | |
| AST (U/L) ± SE | 103 ± 7 | |
| Genotype 1-4 vs others | 115 vs 74 | 61 vs 39% |
| Anti-Hp positive antibody | 60 | 31.8% |
| Gastrin (pg/ml)(median ± SE) | 52.0 ± 10.4 | |
| TSH (UI/ml) | 2.2 ± 0.15 | |
| ANA positive (n) | 34 | 18% |
| AMA positive (n) | - | |
| ASMA positive (n) | 57 | 30% |
| LKM positive (n) | 1 | 0.5% |
| APCA positive (n) | 3 | 1.6% |
| ATM positive (n) | 15 | 7.8% |
| Liver histology (n) | ||
| CAH without cirrhosis (n) | 138 | 73% |
| CAH with cirrhosis (n) | 51 | 27% |
- Citation: Fabbri C, Jaboli MF, Giovanelli S, Azzaroli F, Pezzoli A, Accogli E, Liva S, Nigro G, Miracolo A, Festi D, Colecchia A, Montagnani M, Roda E, Mazzella G. Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy. World J Gastroenterol 2003; 9(7): 1487-1490
- URL: https://www.wjgnet.com/1007-9327/full/v9/i7/1487.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i7.1487